Événement

The Ark Life Sciences Series #1 provides an excellent opportunity to exchange with representatives from all relevant sectors (pharmaceutical companies, SMEs, start-ups, academic researchers, investors and public stakeholders) in the field of Antimicrobial Resistance (AMR) in Switzerland and worldwide. It is an occasion to discuss challenges and strategies currently faced in this domain.

This is the perfect opportunity to understand the state of the art of AMR, discover the current therapeutic and diagnostic innovations in the field, and recognise the public and private opportunities to finance these innovations.

The event’s official language is English.

Lien vers le site web: https://www.theark.ch/fr/events/the-ark-life-sciences-series-1-9914?time=futur

Plus d'informations